This is much better than $.50 purchase price, 125% warrant coverage, $.30 exercise price....yes its dilution, but much more favorable than previous rounds. Plus this could very likely go to pay the noteholder off that is getting $.50/shares monthly and selling as fast as they can and constantly putting pressure on the share price. I suspect this is to not get caught in the jam the noteholder put them in around New Year when they converted a several months worth all at once and CYDY didn't have the cash available.....likely when management was trying to take a few days off over the holidays.

As long as they don't request increase to AS, I'm not concerned of this impacting non-dilutive financing that is likely in the works.